- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02321566
Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.
February 14, 2019 updated by: Johns Hopkins University
This study is an open-label study to determine the feasibility of Motor Cortex Stimulation (MCS) in the treatment of patients with chronic pain of the face or upper extremity.
MCS will be delivered by use of an electrode and pulse generator, which are FDA approved for spinal cord stimulation but are not approved for MCS.
The study has as a single-arm design with the subject at baseline serving as a control for the response to MCS.
Study Overview
Status
Terminated
Conditions
- Glossopharyngeal Neuralgia
- Trigeminal Neuralgia (Burchiel Type I)
- Trigeminal Neuralgia (Burchiel Type II)
- Trigeminal Neuropathic Pain
- Trigeminal Deafferentation Pain
- Complex Regional Pain Syndrome (Types I and II, Involving the Upper Extremity)
- Upper Extremity Pain Due to Deafferentation of the Cervical Spine
- Central Pain Syndromes
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- The Johns Hopkins Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males and females who are greater than 18 years of age.
Subject has a diagnosis of chronic pain involving the face, upper extremity, or throat, as determined by a review of medical records, history and physical examination. The types of chronic pain eligible for the study are:
- Facial pain, including trigeminal neuralgia Type 1, trigeminal neuralgia Type 2, trigeminal neuropathic pain, trigeminal deafferentation pain, symptomatic trigeminal neuralgia, and postherpetic neuralgia.
- Complex Regional Pain Syndrome (Types I and II) involving the arm.
- Both chronic and episodic forms of refractory Glossopharyngeal Neuralgia (GN).
- Deafferentation of the cervical spine leading to pain of the upper extremity.
- Central pain syndromes resulting from a prior cerebrovascular insult occurring at least 5 years prior to the study.
- Subject determined to be treatment-resistant for at least one year prior to the Screening Visit as demonstrated by clinical evidence (determined by review of medical records and discussion with referring pain specialist, anesthesiologist, or neurologist treating chronic pain). The patient must not have responded to treatment with three adequate regimens of medication including one in each of the following categories: antiepileptic drugs, opioids, and antidepressant medications. The trial period for each medication should be at least four weeks, and the two trials must be within the previous 5 years.
- Subject has at least a score of 6 on the Visual Analog Scale of Pain at all three clinic visits prior to undergoing surgery.
- Subject must be ambulatory.
- Females who are postmenopausal, physically incapable of childbearing, or practicing an acceptable method of birth control. Acceptable methods of birth control include surgical sterilization, hormonal contraceptives, or double-barrier methods (condom or diaphragm with a spermicidal agent or intrauterine device [IUD]). If practicing an acceptable method of birth control, a negative urine pregnancy test result has been obtained at baseline Visits 1 and 2.
- Subject is assessed by psychologist with respect to i) the role of psychological factors, including psychological comorbidities, in their chronic pain, ii) their ability to rate pain and make decisions during the extraoperative stimulation trial, and iii) to participate in decision-making capacity to provide informed consent.
- Subject is able to read English, understand and cooperate with study procedures, and has signed a written informed consent form prior to any study procedures.
Exclusion Criteria:
- Subject had major surgery within three months prior to Baseline Visit 1 or has other surgery planned during the proposed study period.
- Subject is determined by medical consultant to have medical contraindications to undergoing surgery.
- Subject is pregnant or breast-feeding.
- Subject has a history of alcohol or drug abuse within the past 6 months and dependence within the past year.
- Subject has a medical illness/condition, co-morbid psychiatric illness, and/or abnormal diagnostic finding that would interfere with the completion of the study, confound the results of the study, or pose risk to the patient.
- Subject has a diagnosis of mental retardation.
- Subject has a distinct neurological condition not included in the list of chronic pain syndromes studied in this protocol, or a history of traumatic brain injury associated with loss of consciousness of > 1 hour and/or intracranial/epidural/subdural bleeding.
- Diagnosis of a somatoform pain disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment Arm
A craniotomy will be performed for the placement of an epidural motor cortex stimulation lead in the context of subjects with chronic facial, upper extremity, and throat pain.
If the stimulation is successful during a trial period with externalized lead cabling, the system cabling will be internalized and connected to an internal implantable pulse generator to power and control the system for the duration of the trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Assessments
Time Frame: 58 weeks after trial entry
|
As measured by the VAS scale of Pain Intensity and Unpleasantness, the McGill Pain questionnaire, and the Leeds Assessment of Neuropathic Signs and Symptoms
|
58 weeks after trial entry
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Frederick A Lenz, MD, PhD, Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2015
Primary Completion (Actual)
November 21, 2017
Study Completion (Actual)
November 21, 2017
Study Registration Dates
First Submitted
December 17, 2014
First Submitted That Met QC Criteria
December 17, 2014
First Posted (Estimate)
December 22, 2014
Study Record Updates
Last Update Posted (Actual)
February 18, 2019
Last Update Submitted That Met QC Criteria
February 14, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Pathologic Processes
- Nervous System Diseases
- Pain
- Neurologic Manifestations
- Disease
- Neuromuscular Diseases
- Stomatognathic Diseases
- Mouth Diseases
- Peripheral Nervous System Diseases
- Cranial Nerve Diseases
- Autonomic Nervous System Diseases
- Facial Nerve Diseases
- Trigeminal Nerve Diseases
- Facial Neuralgia
- Syndrome
- Neuralgia
- Complex Regional Pain Syndromes
- Reflex Sympathetic Dystrophy
- Somatoform Disorders
- Trigeminal Neuralgia
- Causalgia
- Glossopharyngeal Nerve Diseases
Other Study ID Numbers
- NA_00093333
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glossopharyngeal Neuralgia
-
Klinikum Klagenfurt am WörtherseeUniversity of KlagenfurtCompletedGlossopharyngeal Neuralgia | Trigeminal Neuralgia, Idiopathic | Postherpetic; Neuralgia, Trigeminal (Etiology) | Atypical Facial PainAustria
-
Duke UniversityEli Lilly and CompanyCompletedTrigeminal Neuralgia | Glossopharyngeal NeuralgiaUnited States
-
Centre Hospitalier de ValenceCompletedSensation Disorders | Taste Disorders | Taste, Metallic | Taste Disorder, Glossopharyngeal NerveFrance
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPost Herpetic NeuralgiaUnited States, Colombia, South Africa, Hong Kong, Ukraine, Bulgaria, Croatia, India, Sweden, Czechia, Denmark, Germany, Poland, Russian Federation, Serbia, Slovakia, Taiwan
-
Bial - Portela C S.A.Terminated
-
Odense University HospitalCompletedPost Herpetic NeuralgiaDenmark
-
DepomedCompletedPost Herpetic NeuralgiaUnited States
-
PfizerCompletedPostherpetic NeuralgiaUnited States
-
Yonsei UniversityWithdrawnThe Evaluation of Erector Spinae Plane Block for the Pain Control of Thoracic Postherpetic NeuralgiaThoracic Postherpetic NeuralgiaKorea, Republic of
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPostherpetic Neuralgia ( PHN )China
Clinical Trials on Epidural Motor Cortex Stimulation
-
Catholic University, ItalyMedtronicCompleted
-
Nova Scotia Health AuthorityDalhousie UniversityCompletedComplex Regional Pain Syndrome | Neuropathic Pain | Facial Pain | Phantom Limb Pain | Brachial Plexus Avulsion | Stump Pain | Deafferentation PainCanada
-
Assistance Publique - Hôpitaux de ParisUnknownParkinson DiseaseFrance
-
Samsung Medical CenterCompletedStrokeKorea, Republic of
-
HaEmek Medical Center, IsraelRambam Health Care Campus; Technion, Israel Institute of TechnologyNot yet recruiting
-
Assiut UniversityCompletedPain, PostoperativeEgypt, United Kingdom
-
Aalborg UniversityDanish National Research FoundationCompletedAcute Pain | Neuroplasticity | Brain Modulation | Somatosensory FunctionDenmark
-
University of British ColumbiaCompleted
-
University Hospital, GrenobleCompletedChronic Migraine as Defined by Criteria of International Headache Society (IHS)France
-
Abbott Medical DevicesUnknownNeuropathic Pain | Facial Pain | Post-stroke Pain | Brachial Plexus Avulsion | Phantom Limb Pain of the Upper ExtremitiesBrazil